证券代码：001335 证券简称：信凯科技 公告编号：2025-041 浙江信凯科技集团股份有限公司 关于召开 2026 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 浙江信凯科技集团股份有限公司（以下简称"公司"）于2025年12月22日召开第 二届董事会第十二次会议，审议通过了《关于召开2026年第一次临时股东会的议案》， 决定于2026年1月9日召开公司2026年第一次临时股东会（以下简称"本次会议"或"本 次股东会"），现将本次会议的有关情况通知如下： 一、召开会议的基本情况 (一) 股东会届次：2026 年第一次临时股东会 (二) 股东会的召集人：公司董事会 (三) 会议召开的合法、合规性：本次股东会的召开符合有关法律法规、规范性文 件及《公司章程》的有关规定。 (四) 会议召开的日期与时间： 1. 现场会议召开时间：2026 年 1 月 9 日（星期五）下午 14:30 2. 网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2026 年 1 月 9 日上午 9:15-9:25、9:30-11:30，下 ...

证券代码：001335 证券简称：信凯科技 公告编号：2025-039 浙江信凯科技集团股份有限公司 第二届董事会第十二次会议决议公告 本议案已经公司独立董事专门会议审议通过。保荐人出具了无异议的核查意 见。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江信凯科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 16 日 以电子邮件的方式向全体董事发出了关于召开公司第二届董事会第十二次会议 的通知。本次会议于 2025 年 12 月 22 日在公司会议室以现场与通讯表决相结合 方式召开，会议应参加董事 7 人，实际参加董事 7 人（其中李武先生、沈日炯先 生、施放先生、梁伟亮先生通过通讯方式参加会议）。会议由董事长李治先生召 集并主持，高级管理人员列席了会议。本次会议的召开符合《中华人民共和国公 司法》等有关法律、法规和《浙江信凯科技集团股份有限公司章程》（以下简称 《公司章程》）、《董事会议事规则》的有关规定。公司董事审议通过如下议案： 二、董事会会议审议情况 1、审议通过了《关于 2026 年度日常关联交易预计的 ...

Core Viewpoint - Xinkai Technology has experienced a continuous decline in the number of shareholders, indicating potential concerns regarding investor confidence and stock performance [2] Shareholder Information - As of December 20, the number of shareholders for Xinkai Technology was 7,029, a decrease of 523 from the previous period (December 10), representing a decline of 6.93% [2] - This marks the fourth consecutive period of decline in the number of shareholders [2] Stock Performance - The closing price of Xinkai Technology was 45.84 yuan, with a slight increase of 0.26%, but the stock has cumulatively decreased by 2.78% since the concentration of shares began [2] - The stock experienced three days of increases and five days of decreases during this period [2] Financing and Margin Data - As of December 19, the latest margin trading balance for the stock was 106 million yuan, with the financing balance also at 106 million yuan [2] - The financing balance has decreased by 13.33 million yuan during the current concentration period, reflecting a decline of 11.16% [2] Financial Performance - According to the third-quarter report, Xinkai Technology achieved a total operating revenue of 1.024 billion yuan, a year-on-year decrease of 2.85% [2] - The net profit for the same period was 64.0945 million yuan, down 11.21% year-on-year [2] - The basic earnings per share were reported at 0.7700 yuan, with a weighted average return on equity of 7.71% [2]

Core Viewpoint - Xinkai Technology's stock performance shows a slight increase, but financing activities indicate a net outflow, reflecting potential investor caution amid declining revenue and profit figures [1][2]. Group 1: Stock Performance and Financing - On December 19, Xinkai Technology's stock rose by 0.37%, with a trading volume of 52.72 million yuan [1]. - The financing data for December 19 shows a financing buy of 4.40 million yuan and a financing repayment of 14.85 million yuan, resulting in a net financing outflow of 10.45 million yuan [1]. - As of December 19, the total financing and securities balance for Xinkai Technology is 106 million yuan, which accounts for 9.91% of its market capitalization [1]. Group 2: Shareholder and Financial Performance - As of December 10, the number of shareholders for Xinkai Technology is 7,552, a decrease of 18.31% from the previous period [2]. - The average number of circulating shares per shareholder is 3,103, which has increased by 22.42% [2]. - For the period from January to September 2025, Xinkai Technology reported a revenue of 1.02 billion yuan, a year-on-year decrease of 2.85%, and a net profit attributable to shareholders of 64.09 million yuan, down 11.21% year-on-year [2].

Group 1 - The core viewpoint of the news is that Xinkai Technology's stock has shown fluctuations, with a recent increase of 2.08% and a current price of 46.60 yuan per share, while the company has experienced an 11.51% decline in stock price year-to-date [1] - As of December 10, the number of shareholders for Xinkai Technology is 7,552, a decrease of 18.31% from the previous period, while the average circulating shares per person increased by 22.42% to 3,103 shares [2] - The company has reported a revenue of 1.024 billion yuan for the period from January to September 2025, reflecting a year-on-year decrease of 2.85%, and a net profit attributable to shareholders of 64.0945 million yuan, down 11.21% year-on-year [2] Group 2 - Xinkai Technology's main business involves the development, sales, and service of organic pigments, with the revenue composition being 65.59% from azo pigments, 19.30% from heterocyclic pigments, and smaller contributions from other pigment types [1] - The company has cumulatively distributed 14.0609 million yuan in dividends since its A-share listing [3] - The company is categorized under the basic chemical industry, specifically in chemical products related to coatings and inks, and is associated with concepts such as the Belt and Road Initiative and small-cap stocks [2]

（编辑 王雪儿） 证券日报网讯 12月17日晚间，信凯科技发布公告称，中汇会计师事务所受公司委托为公司提供2025年 度财务报告及内部控制审计服务，原指派许菊萍女士担任公司2025年度审计项目质量控制复核人，因中 汇会计师事务所质控工作内部调整及工作安排的需要，现指派孙业亮先生担任质量控制复核人。 ...

证券代码：001335 证券简称：信凯科技 公告编号：2025-038 浙江信凯科技集团股份有限公司 关于变更 2025 年度审计机构项目质量控制复核人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 浙江信凯科技集团股份有限公司（以下简称"公司"）于2025年6月3日召开 第二届董事会第八次会议及第二届监事会第六次会议，审议通过了《关于续聘中 汇会计师事务所（特殊普通合伙）担任公司2025年度审计机构的议案》，同意续 聘中汇会计师事务所（特殊普通合伙）（以下简称"中汇会计师事务所"）为公 司2025年度审计机构，该议案已于2025年6月25日经公司2024年度股东会审议通 过。具体内容详见公司于2025年6月5日、2025年6月25日在巨潮资讯网 （www.cninfo.com.cn）上刊登的《关于续聘2025年度审计机构的公告》（公告 编号：2025-022）等公告。 二、本次变更的质量控制复核人信息 1. 基本信息 | | | 成为注册 | | 开始从事上 | | 开始在中汇 | | 开始为本 | 近三年签署及 | | --- | --- | -- ...

Group 1 - The core point of the article is that Xinkai Technology (001335) reported its total number of shareholders as 7,552 as of December 10 [1]

Core Viewpoint - The company, Xinkai Technology (001335.SZ), has lower R&D expenses compared to domestic peers due to differences in R&D models and directions [1] Group 1: R&D Expenses Comparison - The company's R&D expenses are lower than those of other listed companies in the industry primarily because its focus is on product development, application development, and customized services rather than on manufacturing [1] - Other companies in the industry incur higher R&D costs related to production, including expenses for technology R&D, pilot testing, production equipment, raw materials, and personnel salaries [1] Group 2: Future R&D Investment - The company anticipates an increase in R&D expenses as its own manufacturing base and future R&D center become operational [1]

Core Viewpoint - Xinkai Technology (001335.SZ) is currently in the trial production phase for its subsidiary, Liaoning Xinkai Ziyuan New Materials Co., Ltd, which is expected to last approximately one year [1] Group 1: Production Status - The factory is designed according to the latest national safety standards and employs a full-process microchannel technology [1] - The production ramp-up period is influenced by market demand and product competitiveness, with typical chemical companies taking about 2-3 years to reach full production after official launch [1] - The actual timeline for achieving full production is difficult to predict due to the new challenges posed by the new technology in product manufacturing [1]